From Casetext: Smarter Legal Research

Primed Pharm. v. Starr Indem. & Liab. Co.

United States District Court, S.D. New York
Sep 9, 2021
Civil Action 21 Civ. 1025 (PGG) (SLC) (S.D.N.Y. Sep. 9, 2021)

Opinion

Civil Action 21 Civ. 1025 (PGG) (SLC)

09-09-2021

PRIMED PHARMACEUTICALS, LLC, Plaintiff, v. STARR INDEMNITY & LIABILITY COMPANY, Defendant.


ORDER

SARAH L. CAVE, UNITED STATES MAGISTRATE JUDGE

Pursuant to the Telephone Conference held today, September 9, 2021, the Court orders as follows:

1. Plaintiff PriMed Pharmaceuticals, LLC (“PriMed”) has produced to Defendant Starr Indemnity & Liability Company (“Starr”) additional documents since the last Telephone Conference on August 23, 2021 (the “Additional Production”). Starr shall complete its review of the Additional Production, and by Thursday, September 30, 2021, the parties shall file a joint letter either certifying that discovery is complete, or setting forth the additional discovery, if any, that any party believes is necessary before moving on to dispositive motions, or requesting a conference to resolve any remaining discovery issues.

SO ORDERED.


Summaries of

Primed Pharm. v. Starr Indem. & Liab. Co.

United States District Court, S.D. New York
Sep 9, 2021
Civil Action 21 Civ. 1025 (PGG) (SLC) (S.D.N.Y. Sep. 9, 2021)
Case details for

Primed Pharm. v. Starr Indem. & Liab. Co.

Case Details

Full title:PRIMED PHARMACEUTICALS, LLC, Plaintiff, v. STARR INDEMNITY & LIABILITY…

Court:United States District Court, S.D. New York

Date published: Sep 9, 2021

Citations

Civil Action 21 Civ. 1025 (PGG) (SLC) (S.D.N.Y. Sep. 9, 2021)